| Literature DB >> 16548883 |
Wai Fook Leong1, Vincent T K Chow.
Abstract
Insights into the host antiviral strategies as well as viral disease manifestations can be achieved through the elucidation of host- and virus-mediated transcriptional responses. An oligo-based microarray was employed to analyse mRNAs from rhabdomyosarcoma cells infected with the MS/7423/87 strain of enterovirus 71 (EV71) at 20 h post infection. Using Acuity software and LOWESS normalization, 152 genes were found to be downregulated while 39 were upregulated by greater than twofold. Altered transcripts include those encoding components of cytoskeleton, protein translation and modification; cellular transport proteins; protein degradation mediators; cell death mediators; mitochondrial-related and metabolism proteins; cellular receptors and signal transducers. Changes in expression profiles of 15 representative genes were authenticated by real-time reverse transcription polymerase chain reaction (RT-PCR), which also compared the transcriptional responses of cells infected with EV71 strain 5865/Sin/000009 isolated from a fatal case during the Singapore outbreak in 2000. Western blot analyses of APOB, CLU, DCAMKL1 and ODC1 proteins correlated protein and transcript levels. Two-dimensional proteomic maps highlighted differences in expression of cellular proteins (CCT5, CFL1, ENO1, HSPB1, PSMA2 and STMN1) following EV71 infection. Expression of several apoptosis-associated genes was modified, coinciding with apoptosis attenuation observed in poliovirus infection. Interestingly, doublecortin and CaM kinase-like 1 (DCAMKL1) involved in brain development, was highly expressed during infection. Thus, microarray, real-time RT-PCR and proteomic analyses can elucidate the global view of the numerous and complex cellular responses that contribute towards EV71 pathogenesis.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16548883 PMCID: PMC7162300 DOI: 10.1111/j.1462-5822.2005.00644.x
Source DB: PubMed Journal: Cell Microbiol ISSN: 1462-5814 Impact factor: 3.715
Figure 1Kinetics of human rhabdomyosarcoma cell proliferation at 8 and 20 h following infection with two EV71 strains. Untreated control and inactivated EV71‐treated cells were included. Viable cell count (grey bars) was assessed by the trypan blue exclusion technique. Non‐viable cell counts are represented as unfilled bars. The dashed line depicts the starting number of cells at the point of virus inoculation.
Figure 2Immunofluorescence microscopy of uninfected and EV71‐infected RD cells at 8 and 20 h p.i. Infected cells were detected by anti‐EV71 monoclonal antibody, while the cell nuclei were displayed by DAPI staining. A–D. Uninfected RD cells. E–H. RD cells mock‐infected with inactivated EV71 strain MS/7423/87. I–L. RD cells infected with EV71 strain MS/7423/87. M–P. RD cells infected with EV71 strain 5865/Sin/000009.
Microarray data of 58 representative human genes exhibiting significantly altered transcription profiles in response to EV71 strain MS/7423/87 infection of RD cells at 20 h p.i.
| GenBank | Gene | Fold change |
|---|---|---|
| Transcriptional regulators | ||
| NM_004387 | Cardiac‐specific homeo box (NKX2‐5) | −5.035 |
| NM_002096 | General transcription factor IIF, polypeptide 1 (74 kDa subunit) (GTF2F1) | +2.454 |
| NM_002699 | POU domain, class 3, transcription factor 1 (POU3F1) | −5.988 |
| NM_006195 | Pre‐B‐cell leukaemia transcription factor 3 (PBX3) | −4.179 |
| Cell cycle | ||
| NM_001274 | CHK1 (checkpoint, S. pombe) homologue (CHEK1) | −4.252 |
| NM_001259 | Cyclin‐dependent kinase 6 (CDK6) | −3.048 |
| Cell adhesion | ||
| NM_005102 | Fasciculation and elongation protein zeta 2 (zygin II) (FEZ2) | −4.284 |
| NM_203487 | Protocadherin 9 (PCDH9) | −39.152 |
| NM_007008 | Reticulon 4 (RTN4) | −3.834 |
| Extracellular transport proteins | ||
| NM_006432 | Niemann‐Pick disease, type C2 (NPC2) | −2.310 |
| NM_002305 | Lectin, galactoside‐binding, soluble, 1 (galectin 1) (LGALS1) | −3.546 |
| Oncogenes and tumour suppressors | ||
| NM_006875 | pim‐2 oncogene (PIM2) | −2.601 |
| NM_000321 | Retinoblastoma 1 (including osteosarcoma) (RB1) | −3.858 |
| NM_004985 | v‐Ki‐ras2 Kirsten rat sarcoma 2 viral oncogene homologue (KRAS2) | −4.211 |
| Stress response proteins | ||
| Y00371 | Heat shock 70 kDa protein 8 (HSPA8) | −2.373 |
| NM_000454 | Superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1, adult) (SOD1) | −2.478 |
| Membrane channels and transporters | ||
| NM_001689 | ATP synthase, H + transporting, mitochondrial F0 complex, subunit c (subunit 9) isoform 3 (ATP5G3) | −3.717 |
| NM_000593 | ATP‐binding cassette, subfamily B (MDR/TAP), member 2 (TAP1) | +3.816 |
| Trafficking and targeting proteins | ||
| NM_001283 | Adaptor‐related protein complex 1, sigma 1 subunit (AP1S1) | +3.571 |
| NM_004835 | Angiotensin receptor 1B (AGTR1) | −3.288 |
| NM_007033 | Similar to S. cerevisiae RER1 (RER1) | −3.633 |
| NM_003100 | Sorting nexin 2 (SNX2) | −4.464 |
| Cellular metabolism | ||
| NM_000672 | Alcohol dehydrogenase 6 (class V) (ADH6) | −8.140 |
| NM_004718 | Cytochrome | −3.893 |
| NM_000769 | Cytochrome P450, subfamily IIC (mephenytoin 4‐hydroxylase), polypeptide 19 (CYP2C19) | −4.014 |
| NM_001931 | Dihydrolipoamide S‐acetyltransferase (E2 component of pyruvate dehydrogenase complex) (DLAT) | −3.918 |
| NM_002539 | Ornithine decarboxylase 1 (ODC1) | −2.526 |
| NM_000367 | Thiopurine S‐methyltransferase (TPMT) | −5.111 |
| Post‐translational modification | ||
| NM_006585 | Chaperonin containing TCP1, subunit 8 (theta) (CCT8) | −2.934 |
| NM_000801 | FK506‐binding protein 1 A (12 kDa) (FKBP1A) | −2.626 |
| NM_015929 | Lipoyltransferase (LIPT1) | +2.288 |
| Translational machinery | ||
| NM_001404 | Eukaryotic translation elongation factor 1 gamma (eEF1G) | −2.619 |
| NM_001967 | Eukaryotic translation initiation factor 4 A, isoform 2 (eIF4A2) | −2.565 |
| NM_000998 | Ribosomal protein L37a (RPL37A) | −3.224 |
| M77234 | Ribosomal protein S3A (RPS3A) | −3.519 |
| Apoptosis‐associated proteins | ||
| NM_004052 | BCL2/adenovirus E1B 19 kDa‐interacting protein 3 (BNIP3) | −2.603 |
| M74816 | Clusterin (complement lysis inhibitor, SP‐40,40, sulphated glycoprotein 2, testosterone‐repressed prostate message 2, apolipoprotein J) (CLU) | +2.083 |
| D42055 | Neural precursor cell expressed, developmentally downregulated 4 (NEDD4) | −4.371 |
| NM_002787 | Proteasome (prosome, macropain) subunit, alpha type, 2 (PSMA2) | −3.422 |
| RNA processing, turnover and transport | ||
| NM_004396 | DEAD/H box polypeptide 5 (RNA helicase, 68 kDa) (DDX5) | −6.570 |
| NM_001363 | Dyskeratosis congenita 1, dyskerin (DKC1) | −7.402 |
| DNA binding and chromatin proteins | ||
| NM_006026 | H1 histone family, member X (H1FX) | −6.325 |
| NM_004538 | Nucleosome assembly protein 1‐like 3 (NAP1L3) | −7.653 |
| Cellular receptors | ||
| NM_000739 | Cholinergic receptor, muscarinic 2 (CHRM2) | +2.509 |
| NM_000208 | Insulin receptor (INSR) | −15.573 |
| NM_004736 | Xenotropic and polytropic retrovirus receptor (XPR1) | −4.135 |
| Cell signalling, extracellular communication | ||
| NM_000882 | Interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) (IL12A) | −3.840 |
| NM_002415 | Macrophage migration inhibitory factor (glycosylation‐inhibiting factor) (MIF) | −2.815 |
| NM_003236 | Transforming growth factor, alpha (TGFA) | −4.287 |
| Intracellular transducers/effectors/modulators | ||
| NM_004734 | Doublecortin and CaM kinase‐like 1 (DCAMKL1) | +14.805 |
| NM_001946 | Dual specificity phosphatase 6 (DUSP6) | −4.022 |
| NM_003479 | Protein tyrosine phosphatase type IVA, member 2 (PTP4A2) | −4.475 |
| Cytoskeleton/motility | ||
| NM_001613 | Actin, alpha 2, smooth muscle, aorta (ACTA2) | +2.196 |
| NM_005159 | Actin, alpha, cardiac muscle (ACTC) | −2.339 |
| NM_000384 | Apolipoprotein B (including Ag(x) antigen) (APOB) | +5.184 |
| NM_005690 | Dynamin 1‐like (DNM1L) | −2.277 |
| NM_003283 | Troponin T1, skeletal, slow (TNNT1) | −3.514 |
| NM_003295 | Tumour protein, translationally controlled 1 (TPT1) | −3.511 |
Upregulated and downregulated transcripts are indicated as ‘+’ and ‘–’ values respectively.
Real‐time RT‐PCR analyses of 15 selected genes expressed in RD cells at 8 and 20 h following infection with EV71 strains MS/7423/87 (MS) and 5865/Sin/000009 (SIN).
| Gene | Fold change | ||||||
|---|---|---|---|---|---|---|---|
| Microarrayanalysis | RT‐PCR 8 h p.i. | RT‐PCR 20 h p.i. | |||||
| Mock | EV71 (MS) | EV71 (SIN) | Mock | EV71 (MS) | EV71 (SIN) | ||
| CDK6 | −3.05 | −1.02 | +1.37 | +1.80 | 1.00 | −2.94 (0.013) | −3.43 (0.031) |
| eEF1G | −2.62 | +1.08 | +1.50 (0.034) | +1.80 (0.023) | −1.08 | −2.85 (0.039) | −3.56 (0.025) |
| IL12A | −3.84 | +1.23 | −1.01 | +1.28 | −1.14 | −2.60 (0.009) | −3.15 (0.018) |
| NPC2 | −2.31 | −1.08 | +1.24 | +3.19 (0.013) | +1.04 | −2.58 (0.004) | −3.07 (0.002) |
| ODC1 | −2.53 | +1.08 | +1.11 | +1.25 | +1.10 | −2.99 (0.007) | −2.35 (0.017) |
| PIM2 | −2.60 | +1.10 | +1.11 | +1.30 | +1.20 | −2.69 (0.027) | −3.17 (0.008) |
| PSMA2 | −3.42 | +1.04 | +1.33 | +1.27 | +1.17 | −4.61 (0.001) | −4.71 (0.001) |
| TPT1 | −3.51 | −1.05 | +1.09 | +1.78 (0.036) | +1.27 | −3.16 (0.008) | −3.07 (0.006) |
| ACTA2 | +2.20 | 1.00 | +4.07 (0.020) | +5.05 (0.006) | +1.21 | +7.75 (0.001) | +8.25 (0.011) |
| AP1S1 | +3.57 | −1.23 | −1.12 | −1.16 | +1.03 | +3.59 (0.030) | +3.31 (0.022) |
| APOB | +5.18 | +1.02 | −1.02 | −1.03 | −1.02 | +8.97 (0.005) | +6.57 (0.007) |
| CHRM2 | +2.51 | +1.04 | +3.11 (0.028) | +3.05 (0.004) | −1.23 | +2.27 (0.033) | +2.14 (0.037) |
| CLU | +2.08 | −1.25 | −1.45 | −1.32 | −1.11 | +3.59 (0.015) | +3.31 (0.030) |
| DCAMKL1 | +14.81 | +1.12 | +1.20 | +1.35 | +1.09 | +35.88 (0.013) | +36.25 (0.033) |
| GTF2F1 | +2.45 | +1.03 | −1.08 | +1.41 | +1.04 | +2.73 (0.004) | +2.80 (0.004) |
Samples were normalized with GAPDH as the control housekeeping gene, and with uninfected RD cells at each respective time‐point as the reference sample (value of 1). The P‐values denoting significant differences (P < 0.05) are shown within parentheses.
Figure 3Western blot analysis of ODC1, DCAMKL1, APOB and CLU expression at 8 and 20 h p.i. Total protein extracts (20 µg each) of uninfected control (C), mock‐infected (I), EV71 MS/7423/87 strain‐infected (M), and EV71 5865/Sin/000009 strain‐infected (S) RD cells were tested against the relevant specific antibodies. The GAPDH housekeeping protein was included to ensure equal loading of protein samples.
Figure 4RT‐PCR amplification of the p53 gene at 8 and 20 h p.i. A 353 bp fragment representing the wild‐type p53 transcript was amplified in uninfected control (C), mock‐infected (I), EV71 MS/7423/87 strain‐infected (M), and EV71 5865/Sin/000009 strain‐infected (S) RD cells. An additional 486 bp fragment corresponding to the p53 splice variant appeared more distinctly in cells infected with the two EV71 strains after 20 h. GAPDH (153 bp fragment) served to ensure equal amounts of starting template in the samples.
Figure 5Identification of six differentially expressed proteins by two‐dimensional proteomic analysis of uninfected (U) and EV71 MS/7423/87 strain‐infected (I) RD cell samples at 8 and 20 h p.i. The arrowheads indicate the protein spots identified as differentially regulated at greater than twofold changes (P < 0.05) using Delta2D analysis.
Sequences of primers for real‐time RT‐PCR amplification of selected genes.
| Gene | Primer sequence (5′→3′) | Target size(bp) | |
|---|---|---|---|
| Sense | Anti‐sense | ||
| ACTA2 | ATTGACATCAGGAAGGACCT | TGTGTGCTAGAGACAGAGAG | 305 |
| AP1S1 | TGCCAGCCTCTACTTCTGCT | CGATGGCTTTCAGCACACTC | 221 |
| APOB | GCTTCAGCCATTGACATGAG | CTTTGTGTTCAAGAGCTGCA | 277 |
| CDK6 | AAGAATGTTGGCAGGTGACT | TTCAAGAGGGCTTTCTGTGT | 258 |
| CHRM2 | AACCCAGGATGAAAACACAG | GTGATGATGAAAGCCAACAG | 294 |
| CLU | ATTCTGACCAAGGTGCGACA | TGGACAGGAAATGCCACAGT | 265 |
| DCAMKL1 | GCCTGAGTTTCTTCTGGAAC | TACTGTTCAGCCACCAGATG | 209 |
| eEF1G | TCAGACCTTCATGAGCTGCA | TACTCTCGAACCAGCGTCTG | 249 |
| EV71VP1 | TTCAGTAGGGCAGGCTTGGT | GTCTGCCAAGCGAGTGATTC | 269 |
| GAPDH | AGGTGAAGGTCGGAGTCAAC | CATGGGTGGAATCATATTGG | 153 |
| GTF2F1 | GACCACTAAGGACCTGCTGA | AGTCAGGGAGCAAGCAGGAT | 303 |
| IL12A | CCAGGTGGAGTTCAAGAC | ACAACGGTTTGGAGGGAC | 285 |
| NPC2 | AGCTCTGCTGCTTCAACAAC | AGGTGTAGAAAGAGGCCACA | 223 |
| ODC1 | ATACTCTATGACCACGCACA | GCCCTGACATCACATAGTAG | 250 |
| PIM2 | GGAGATTCTGGAAGCTGAG | TGTCCATCTATCCCTGTGA | 286 |
| PSMA2 | AAGGGCAAATGACAGAGGAT | TGGAAGGTGGGTTTAACAGT | 276 |
| TPT1 | ACCGAAAGCACAGTAATCAC | CACGGTAGTCCAATAGAGCA | 274 |
. Housekeeping gene serving as the normalization control.